Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.34% | -59.44% | - | - | 92.63K | |
| +0.04% | +2.67% | +51.68% | +100.28% | 1,027B | |
| -0.09% | +1.37% | +52.36% | +67.23% | 651B | |
| -0.02% | +3.51% | +19.54% | +73.52% | 467B | |
| -1.22% | +3.27% | +37.02% | +36.52% | 350B | |
| -0.79% | +2.64% | +19.18% | +24.76% | 268B | |
| +0.58% | +6.31% | +9.69% | +14.26% | 257B | |
| +1.55% | +0.83% | +40.38% | +47.92% | 205B | |
| +0.79% | -1.66% | -23.80% | -57.76% | 190B | |
| -0.52% | +3.66% | +33.72% | +98.37% | 187B | |
| Average | -5.03% | +2.49% | +26.64% | +45.01% | 400.23B | |
| Weighted average by Cap. | +0.13% | +2.62% | +35.25% | +61.48% |
Employees
4
Sector
Pharmaceuticals
